BIOTECH

Pulsesight Therapeutics Presents Pst 611 Ever Congress 2024

BIOTECH

PulseSight Therapeutics to Present Data on PST-611 at EVER Congress 2024
October 7, 2024

PARIS, Oct. 07, 2024 (GLOBE NEWSWIRE) — PulseSight Therapeutics SAS, an ophthalmology biotech company developing...

Read more
Mimi Tang Prota Therapeutics Forbes Australia

BIOTECH

Forbes Australia recognizes Prota Therapeutics for making waves in Australia’s startup scene at the moment
June 24, 2024

June 18, 2024 – (Forbes Australia) – Founder and CEO Mimi Tang has spent almost...

Read more
Biosenic On Its Way To Find The Necessary Funds To Perform Its Key Clinical Trial On Chronic Graft Versus Host Disease

BIOTECH

Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments
January 16, 2024

Prota Therapeutics Pty Ltd (Prota), an Australian biotechnology company focused on the development of novel...

Read more
Spexis Provides Update Regarding Debt Restructuring Moratorium

BIOTECH

Stalicla Secures $17.4 Million in Series B Financing
January 16, 2024

Stalicla SA, a clinical-stage biopharmaceutical company advancing precision medicine pipelines for neuropsychiatric and neurological disorders,...

Read more
Spexis Provides Business Update And Announces Financial Results For The First Half Of 2023

BIOTECH

Spexis provides business update and announces financial results for the first half of 2023
September 29, 2023

Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics for rare diseases...

Read more
This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.
Accept